KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Other financing activities (2016 - 2025)

Chemed (CHE) has 17 years of Other financing activities data on record, last reported at $211000.0 in Q4 2025.

  • For Q4 2025, Other financing activities rose 112.89% year-over-year to $211000.0; the TTM value through Dec 2025 reached $1.1 million, up 155.58%, while the annual FY2025 figure was $1.1 million, 155.58% up from the prior year.
  • Other financing activities reached $211000.0 in Q4 2025 per CHE's latest filing, up from -$178000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.7 million in Q3 2022 and bottomed at -$1.6 million in Q4 2024.
  • Average Other financing activities over 5 years is $50600.0, with a median of $80500.0 recorded in 2022.
  • Peak YoY movement for Other financing activities: surged 26300.0% in 2023, then crashed 410.77% in 2024.
  • A 5-year view of Other financing activities shows it stood at -$228000.0 in 2021, then skyrocketed by 100.88% to $2000.0 in 2022, then soared by 26300.0% to $528000.0 in 2023, then plummeted by 410.04% to -$1.6 million in 2024, then surged by 112.89% to $211000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other financing activities were $211000.0 in Q4 2025, -$178000.0 in Q3 2025, and $933000.0 in Q2 2025.